393 results on '"Gross, Mitchell"'
Search Results
2. Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population.
3. Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration
4. Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population
5. CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation
6. Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
7. Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)
8. MRI Detection of Lymph Node Metastasis through Molecular Targeting of C–C Chemokine Receptor Type 2 and Monocyte Hitchhiking.
9. Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics
10. Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)
11. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis
12. Data from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
13. Supplementary Figure 4 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
14. Supplementary Table 1 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
15. Supplementary Table 2 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
16. Supplementary Figure Legend and Methods from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
17. Supplementary Figure 1 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
18. Supplementary Figure 3 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
19. Supplementary Figure 2 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
20. Supplementary Table 3 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
21. A Transcriptional Corepressor of Stat1 with an Essential LXXLL Signature Motif
22. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate
23. Supplementary Table 1 from Phase I/II Trial of Orteronel (TAK-700)—an Investigational 17,20-Lyase Inhibitor—in Patients with Metastatic Castration-Resistant Prostate Cancer
24. Improved Quantitative Parameter Estimation for Prostate T2 Relaxometry using Convolutional Neural Networks
25. Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)
26. LANDMARKS IN THE LAW: Current developments in judicial law, legislation, and administrative action together with a foretaste of emergent trends in law and the legal profession for the complete Minnesota lawyer.
27. Abstract A019: Phase 1, first-in-human, dose-expansion study of oral TP-1287, a cyclin dependent kinase 9 (CDK9) inhibitor, in patients with sarcoma
28. Applications of Proteomics in Prostate Cancer
29. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial
30. Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies
31. Abstract CT191: Phase 1, first-in-human, dose-escalation study of oral TP-1287, a cyclin dependent kinase 9 (CDK9) inhibitor, in patients (pts) with advanced solid tumors (ASTs)
32. Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer
33. 3-Dimensional Elastic Registration System of Prostate Biopsy Location by Real-Time 3-Dimensional Transrectal Ultrasound Guidance With Magnetic Resonance/Transrectal Ultrasound Image Fusion
34. Soft Magnetic MIM Parts for Diesel Engines
35. A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel
36. MP86-04 NOVEL TECHNIQUES OF THREE-DIMENSIONALLY DOCUMENTED BIOPSY-MAPPING ALLOW SERIAL MONITORING OF CELL-CYCLE PROGRESSION BY RE-VISITING CANCER FOCI
37. Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors
38. Liposomal Malaria Vaccine in Humans: A Safe and Potent Adjuvant Strategy
39. Construction and Identification of Bacterial Plasmids Containing Nucleotide Sequence for Human Leukocyte Interferon
40. DNA Sequence of a Major Human Leukocyte Interferon Gene
41. DNA Sequence of Two Closely Linked Human Leukocyte Interferon Genes
42. Expression of Plasmodium falciparum Circumsporozoite Proteins in Escherichia coli for Potential Use in a Human Malaria Vaccine
43. A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors
44. Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study
45. Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium
46. TRANS-RECTAL ULTRASOUND VISIBILITY OF PROSTATE LESIONS INCREASES ACCURACY OF MR-TRUS IMAGE-FUSION GUIDED BIOPSIES.: MP67-07
47. Genomic characterization and molecular taxonomy of sarcomatoid variant prostate cancer.
48. In Vivo Non-Thermal, Selective Cancer Treatment With High-Frequency Medium-Intensity Focused Ultrasound
49. Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial
50. PROSTATE CANCER: Age is nothing but a number
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.